Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,440Revenue $M74.0Net Margin (%)-150.0Z-Score0.7
Enterprise Value $M2,605EPS $-2.3Operating Margin %-10.4F-Score4
P/E(ttm))0Cash Flow Per Share $-1.7Pre-tax Margin (%)-151.6Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales6.85-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-77.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-468.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M119ROI % (ttm)-72.1Gross Margin Increase y-yY

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 20.5364%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 20.5378%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 20.5344%New holding, 57769 sh.57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HZNP Joel Greenblatt 2014-12-31107,8980.090.01+33.48%
Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.0570.37view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.0570.37view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.0570.37view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.5477.9view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.5477.9view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.5477.9view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$077.9view
DE VAERE ROBERT JEVP & CFO 2014-09-30Sell51,942$12.2867.18view
Watkins ThomasDirector 2014-08-14Buy6,000$9.76110.35view
DE VAERE ROBERT JEVP & CFO 2014-05-19Sell12,939$12.9458.66view

Press Releases about HZNP :

    Quarterly/Annual Reports about HZNP:

    News about HZNP:

    Articles On GuruFocus.com
    Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015 Jan 28 2015 
    Horizon Pharma plc Provides Business Update Jan 12 2015 
    Horizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an Dec 24 2014 
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014 
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholder Nov 14 2014 
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014 
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Table Nov 12 2014 
    Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer Nov 06 2014 
    Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award Oct 31 2014 
    Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc. Oct 17 2014 

    More From Other Websites
    Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP): Deerfield Management Keeps Betting on... Feb 28 2015
    Stocks Drop In Final Hour, But Volume Remains Tame Feb 27 2015
    Horizon Pharma plc Announces Fourth Quarter and Full Year 2014 Financial Results and Raises Guidance... Feb 27 2015
    HORIZON PHARMA PLC Files SEC form 8-K, Change in Directors or Principal Officers Feb 27 2015
    Horizon Pharma Soars On Q4 Beat, Guidance Raise Feb 27 2015
    Horizon Pharma (HZNP) Stock Spikes Today on Raised Guidance Despite Quarterly Earnings Loss Feb 27 2015
    Horizon Pharma reports 4Q loss Feb 27 2015
    Horizon Pharma reports 4Q loss Feb 27 2015
    Q4 2014 Horizon Pharma PLC Earnings Release - Before Market Open Feb 27 2015
    7:04 am Horizon Pharma beats by $0.06, beats on revs; raises FY15 rev and EBITDA guidance Feb 27 2015
    Horizon Pharma plc Announces Fourth Quarter and Full Year 2014 Financial Results and Raises Guidance... Feb 27 2015
    Horizon Pharma plc to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24 2015
    Horizon Pharma plc to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24 2015
    Horizon Pharma plc Celebrates Official Opening of New Global Corporate Headquarters in Dublin Feb 23 2015
    Horizon Pharma plc Celebrates Official Opening of New Global Corporate Headquarters in Dublin Feb 23 2015
    Market Turns Positive As Stocks Stage Reversal Feb 20 2015
    Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog Feb 18 2015
    Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office Feb 17 2015
    Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office Feb 17 2015
    Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of... Feb 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK